Infantile hypercalcemia and hypercalciuria: New insights into a vitamin D-dependent mechanism and response to ketoconazole treatment

Journal of Pediatrics

Volumn 157, Issue 2, 2010, Pages 296-302

  Nguyen, Minh ^a   Boutignon, Henri ^b   Mallet, Eric ^c   Linglart, Agnes ^a   Guillozo, Huguette ^a   Jehan, Frederic ^a   Garabedian, Michele ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Centre Hospitalier Compiegne   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIUM; CREATININE; KETOCONAZOLE; OXYGENASE; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ARTICLE; BINDING AFFINITY; BODY HEIGHT; BODY WEIGHT; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CREATININE URINE LEVEL; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; FGF23 GENE; GENE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERCALCEMIA; HYPERCALCIURIA; INFANT; INFANTILE HYPERCALCEMIA; INFANTILE HYPERCALCIURIA; KIDNEY CALCIFICATION; KLOTHO GENE; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SKIN FIBROBLAST; TREATMENT RESPONSE; UPREGULATION; URINARY EXCRETION; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; BIOSYNTHESIS; BLOOD; DRUG ANTAGONISM; GENETIC POLYMORPHISM; METABOLISM; NEWBORN;

CALCIUM; FEMALE; HAPLOTYPES; HUMANS; HYPERCALCEMIA; HYPERCALCIURIA; INFANT; INFANT, NEWBORN; KETOCONAZOLE; MALE; PARATHYROID HORMONE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; VITAMIN D;

EID: 77955299180     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.02.025     Document Type: Article

References (30)

1. P.H. Finne, J. Sanderud, L. Aksnes, D. Bratlid, and D. Aarskog Hypercalcemia with increased and unregulated 1,25-dihydroxyvitamin D production in a neonate with subcutaneous fat necrosis J Pediatr 112 1988 792 794
2. M. Garabedian, E. Jacqz, H. Guillozo, R. Grimberg, M. Guillot, and M.F. Gagnadoux Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies N Engl J Med 312 1985 948 952
3. T. Stapleton, W.B. MacDonald, and R. Lightwood The pathogenesis of idiopathic hypercalcemia in infancy Am J Clin Nutr 5 1957 533 542
4. W.W. Payne The blood chemistry in idiopathic hypercalcemia Arch Dis Child 27 1952 302
5. J.O. Forfar, S.L. Tompsett, and W. Forshall Biochemical studies in idiopathic hypercalcaemia of infancy Arch Dis Child 34 1959 525 537
6. Y. Mizusawa, and J.R. Burke Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis J Paediatr Child Health 32 1996 350 352
7. U. Alon, D. Berkowitz, and M. Berant Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin Child Nephrol Urol 12 1992 47 50
8. A. Bereket, and T. Erdogan Oral bisphosphonate therapy for vitamin D intoxication of the infant Pediatrics 111 2003 899 901
9. A.R. Glass, and C. Eil Ketoconazole-induced reduction in serum 1,25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients J Clin Endocrinol Metab 66 1988 934 938
10. G. Saggese, S. Bertelloni, G.I. Baroncelli, and G. Di Nero Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia Am J Dis Child 147 1993 270 273
11. J.S. Adams, O.P. Sharma, M.M. Diz, and D.B. Endres Ketoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia J Clin Endocrinol Metab 70 1990 1090 1095
12. S.J. Mc Taggart, J. Craig, J. MacMillan, and J.R. Burke Familial occurrence of idiopathic infantile hypercalcemia Pediatr Nephrol 13 1999 668 671
13. H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, and K.P. Roseblatt Regulation of fibroblast growth factor-23 signaling by Klotho J Biol Chem 281 2006 6120 6123
14. M. Ohnishi, T. Nakatani, B. Lanske, and M.S. Razzaque Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase Kidney Int 75 2009 1166 1172
15. T. Yoshida, T. Fujimori, and Y.I. Nabeshima Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene Endocrinology 143 2002 683 689
16. E.R. Lopez, O. Zwermann, M. Segni, G. Meyer, M. Reincke, and J. Seissler A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans Eur J Endocrinol 151 2004 193 197
17. C.N. Holick, J.L. Stanford, E.M. Kwon, E.A. Ostrander, S. Nejentsev, and U. Peters Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1 and CYP24A1 in prostate cancer Cancer Epidemiol Biomarkers Prev 16 2007 1990 1999
18. A. d'Alesio, M. Garabédian, J.P. Sabatier, G. Guaydier-Souquires, C. Marcelli, and A. Lemaon Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls Hum Mol Genet 14 2005 3539 3548
19. D.E. Arking, A. Krebsova, M. Macek Sr., M. Macek Jr., A. Arking, and I.S. Mian Association of human aging with a functional variant of klotho Proc Natl Acad Sci U S A 99 2002 856 861
20. K. Kawano, N. Ogata, M. Chiano, H. Molloy, P. Kleyn, and T.D. Spector Klotho gene polymorphisms associated with bone density of aged postmenopausal women J Bone Miner Res 17 2002 1744 1751
21. G.D. Carter, C.R. Carter, E. Gunter, J. Jones, G. Jones, H.L. Makin, and S. Sufi Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation J Steroid Biochem Mol Biol 89-90 2004 467 471
22. R.M. Shepard, R.L. Horst, A.J. Hamstra, and H.F. DeLuca Determination of vitamin D and its metabolites in plasma from normal and anephric man Biochem.J 185 1979 55 69
23. T.M. Nguyen, H. Guillozo, M. Garabedian, E. Mallet, and S. Balsan Serum concentration of 24, 25-dihydroxyvitamin D in normal children and in children with rickets Pediatr Res 13 1979 973 976
24. T.M. Nguyen, P. Adiceam, M.L. Kottler, H. Guillozo, M. Rizk-Rabin, and F. Brouillard Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihydroxyvitamin D J Bone Miner Res 17 2002 1728 1737
25. T.M. Nguyen, M. Lieberherr, J. Fritsch, H. Guillozo, M.L. Alvarez, and Z. Fitouri The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity J Biol Chem 279 2004 7591 7597
26. F. Suarez, F. Zeghoud, C. Rossignol, O. Walrant, and M. Garabedian Association between vitamin D receptor gene polymorphism and sex-dependent growth during the first two years of life J Clin Endocrinol Metab 82 1997 2966 2970
27. J.S. Adams, F.R. Singer, M.A. Gacad, O.P. Sharma, M.J. Hayes, and P. Vouros Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis J Clin Endocrinol Metab 60 1985 960 966
28. J. Cadranel, A.J. Hance, B. Milleron, F. Paillard, G. Akoun, and M. Garabedian Vitamin D metabolism in tuberculosis: production of 1,25-(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis Am Rev Resp Dis 138 1988 984 989
29. Y. Weisman, A. Harell, and S. Edelstein Infantile hypercalcemia: a defect in the esterification of 1,25-dihydroxyvitamin D? Med Hypotheses 5 1979 379 382
30. C. Vervel, F. Zeghoud, H. Boutignon, J.C. Tjani, O. Walrant-Debray, and M. Garabedian Fortified milk and oral daily supplements of vitamin D. Comparison of the effects of two doses (500 and 1,000 IU/d) on calcium metabolism and vitamin D status during the first trimester of life Arch Pediatr 4 1997 126 132